| scholarly article | Q13442814 |
| P50 | author | Ralph Steinman | Q105494 |
| Régis Josien | Q48295383 | ||
| P2093 | author name string | Choi Y | |
| Li HL | |||
| Wong BR | |||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | dendritic cell | Q506253 |
| TNF | Q18032037 | ||
| P304 | page(s) | 2562-2568 | |
| P577 | publication date | 1999-03-01 | |
| P1433 | published in | Journal of Immunology | Q3521441 |
| P1476 | title | TRANCE, a TNF family member, is differentially expressed on T cell subsets and induces cytokine production in dendritic cells | |
| P478 | volume | 162 |
| Q37484556 | A novel distal enhancer mediates cytokine induction of mouse RANKl gene expression |
| Q34087699 | A novel helper role for CD4 T cells |
| Q35106581 | Analysis of gene expression in ceca of Helicobacter hepaticus-infected A/JCr mice before and after development of typhlitis. |
| Q38855010 | Autocrine amplification of immature myeloid cells by IL-6 in multiple myeloma-infiltrated bone marrow |
| Q34366449 | Biology of the RANKL-RANK-OPG System in Immunity, Bone, and Beyond |
| Q35229853 | Bone density and hyperlipidemia: the T-lymphocyte connection |
| Q24805600 | Bone loss. Therapeutic approaches for preventing bone loss in inflammatory arthritis |
| Q35798899 | Cervical (pre)neoplastic microenvironment promotes the emergence of tolerogenic dendritic cells via RANKL secretion |
| Q34201118 | Constitutive expression of TNF-related activation-induced cytokine (TRANCE)/receptor activating NF-κB ligand (RANK)-L by rat plasmacytoid dendritic cells |
| Q61797344 | Decidual RANKL/RANK interaction promotes the residence and polarization of TGF-β1-producing regulatory γδ T cells |
| Q42738684 | Dendritic cell maturation and survival are differentially regulated by TNFR1 and TNFR2. |
| Q36056922 | Denosumab in postmenopausal osteoporosis: what the clinician needs to know |
| Q37307805 | Denosumab: an investigational drug for the management of postmenopausal osteoporosis |
| Q28295303 | Disorders of Bone Remodeling |
| Q37265676 | Diverse roles of the tumor necrosis factor family member TRANCE in skeletal physiology revealed by TRANCE deficiency and partial rescue by a lymphocyte-expressed TRANCE transgene |
| Q37767159 | Do RANKL inhibitors (denosumab) affect inflammation and immunity? |
| Q37441693 | Effects of RANKL-Targeted Therapy in Immunity and Cancer |
| Q35604072 | Emergency granulopoiesis promotes neutrophil-dendritic cell encounters that prevent mouse lung allograft acceptance |
| Q21131222 | Emerging Functions of RANKL in Lymphoid Tissues |
| Q27301201 | Functional Local Renin-Angiotensin System in Human and Rat Periodontal Tissue |
| Q33788192 | Gamma interferon positively modulates Actinobacillus actinomycetemcomitans-specific RANKL+ CD4+ Th-cell-mediated alveolar bone destruction in vivo. |
| Q35039002 | Gene-modified dendritic cells for immunotherapy against cancer |
| Q43133501 | IL-15 links TLR2/1-induced macrophage differentiation to the vitamin D-dependent antimicrobial pathway |
| Q49551952 | IL-15 supports the generation of protective lung-resident memory CD4 T cells |
| Q34111806 | Immune responses against a single CD8+-T-cell epitope induced by virus vector vaccination can successfully control Trypanosoma cruzi infection |
| Q33805719 | Immunomodulation by blockade of the TRANCE co-stimulatory pathway in murine allogeneic islet transplantation |
| Q39517388 | Immunopathologic effects of tumor necrosis factor alpha in murine mycobacterial infection are dose dependent |
| Q35724760 | Impairment of organ-specific T cell negative selection by diabetes susceptibility genes: genomic analysis by mRNA profiling |
| Q81009343 | Increased expression of receptor activator of NF-kappaB ligand (RANKL), its receptor RANK and its decoy receptor osteoprotegerin in the colon of Crohn's disease patients |
| Q45024312 | Interactions among human immunodeficiency virus (HIV)-1, interferon-gamma and receptor of activated NF-kappa B ligand (RANKL): implications for HIV pathogenesis |
| Q35553437 | Interleukin (IL) 18 stimulates osteoclast formation through synovial T cells in rheumatoid arthritis: comparison with IL1 beta and tumour necrosis factor alpha |
| Q34248780 | Interleukin-12: an update on its immunological activities, signaling and regulation of gene expression |
| Q53955124 | LPS-stimulated human gingival fibroblasts inhibit the differentiation of monocytes into osteoclasts through the production of osteoprotegerin. |
| Q46069255 | Lesional infiltration of receptor activator of nuclear factor-κB ligand⁺ cells in experimental autoimmune neuritis rats |
| Q24806684 | Mechanisms of bone loss in inflammatory arthritis: diagnosis and therapeutic implications |
| Q34122330 | MicroRNA expression in Sezary syndrome: identification, function, and diagnostic potential |
| Q35664993 | Molecular mechanisms of the biphasic effects of interferon-γ on osteoclastogenesis |
| Q36887852 | Molecular profiling of tumor-specific TH1 cells activated in vivo. |
| Q35063276 | Mouse Rankl expression is regulated in T cells by c-Fos through a cluster of distal regulatory enhancers designated the T cell control region |
| Q38601750 | Muscle Paralysis Induces Bone Marrow Inflammation and Predisposition to Formation of Giant Osteoclasts |
| Q37449635 | NF-κB signaling and bone resorption |
| Q35755039 | Osteoclasts: New Insights |
| Q92854752 | Parathyroid Hormone-Related Protein (PTHrP) Accelerates Soluble RANKL Signals for Downregulation of Osteogenesis of Bone Mesenchymal Stem Cells |
| Q24598872 | RANK is essential for osteoclast and lymph node development |
| Q64939796 | RANK-RANKL Signaling in Cancer of the Uterine Cervix: A Review. |
| Q35766784 | RANKL inhibitors induce osteonecrosis of the jaw in mice with periapical disease |
| Q36412789 | RANKL-RANK interaction in immune regulatory systems |
| Q47109113 | Receptor Activator of NF-κB Orchestrates Activation of Antiviral Memory CD8 T Cells in the Spleen Marginal Zone. |
| Q37362936 | Regulation of dendritic cell survival and cytokine production by osteoprotegerin |
| Q36368551 | Regulation of peripheral lymph node genesis by the tumor necrosis factor family member TRANCE |
| Q34963016 | Role of RANKL and RANK in bone loss and arthritis. |
| Q37344527 | Role of RANKL-RANK/osteoprotegerin pathway in cardiovascular and bone disease associated with HIV infection |
| Q34886943 | Role of periodontal pathogenic bacteria in RANKL-mediated bone destruction in periodontal disease |
| Q49950374 | STAC2 negatively regulates osteoclast formation by targeting the RANK signaling complex |
| Q35689812 | Safety and tolerability of denosumab for the treatment of postmenopausal osteoporosis |
| Q37143375 | Selective inhibition of RANK blocks osteoclast maturation and function and prevents bone loss in mice |
| Q34090842 | Selective targeting of RANK signaling pathways as new therapeutic strategies for osteoporosis. |
| Q85849560 | Serum osteoprotegerin is markedly increased and may contribute to decreased blood T cell count in hemodialysis patients |
| Q33782305 | Signal transduction by tumour necrosis factor and tumour necrosis factor related ligands and their receptors |
| Q36375923 | TRANCE, a tumor necrosis factor family member, enhances the longevity and adjuvant properties of dendritic cells in vivo |
| Q98771227 | Targeting the RANKL/RANK/OPG Axis for Cancer Therapy |
| Q36356112 | The E3 ubiquitin ligase Cbl-b improves the prognosis of RANK positive breast cancer patients by inhibiting RANKL-induced cell migration and metastasis. |
| Q24671078 | The induction of tolerance by dendritic cells that have captured apoptotic cells |
| Q37806610 | The multiple faces of autoimmune-mediated bone loss |
| Q37518524 | The role of CD40 and CD154/CD40L in dendritic cells |
| Q37268896 | The role of T cells in osteoporosis, an update. |
| Q33729251 | Thymic homing of activated CD4+ T cells induces degeneration of the thymic epithelium through excessive RANK signaling |
| Q35001309 | Transcriptional regulation of the human TNFSF11 gene in T cells via a cell type-selective set of distal enhancers |
| Q36380499 | Tumor necrosis factor/tumor necrosis factor receptor family members that positively regulate immunity |
| Q36604777 | Why can't the immune system control HIV-1? Defining HIV-1-specific CD4+ T cell immunity in order to develop strategies to enhance viral immunity |
Search more.